Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

Shuichi Okada, Nobuo Okazaki, Haruhiko Nose, Masayoshi Yoshimori, Kazunori Aoki – 1 July 1992 – A total of 71 consecutive patients with unresectable hepatocellular carcinoma were analyzed retrospectively to determine the significant prognostic factors. All the patients received systemic chemotherapy in a phase 2 study from 1980 to 1990, with no other anticancer treatment. Median survival time and 1‐yr and 2‐yr survival rates were 5.6 mo, 23% and 5%, respectively.

Reversal of fulminant hepatic failure using an extracorporeal liver assist device

Norman L. Sussman, Maria G. Chong, Tarek Koussayer, Da‐Er He, Thomas A. Shang, Hartwell H. Whisennand, James H. Kelly – 1 July 1992 – Liver transplantation is currently the only effective therapy for patients with fulminant hepatic failure. The availability of an artificial liver could bridge these patients through the relatively brief crisis period and allow their own livers to regenerate, providing a more favorable outcome and sparing the trauma and expense of transplant.

Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation

Carlos V. Paya, Russell H. Wiesner, Paul E. Hermans, Jeffrey J. Larson‐Keller, Duane M. Ilstrup, Ruud A. F. Krom, S. Breanndon Moore, Jurgen Ludwig, Thomas F. Smith – 1 July 1992 – In this study we evaluated the association between cytomegalovirus infection alone or in relation to human leukocyte antigen matching and the development of vanishing bile duct syndrome, a form of chronic hepatic allograft rejection.

A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (child class B and C) cirrhotic patients

S. Dasarathy, Manisha Dwivedi, Dinesh K. Bhargava, K. R. Sundaram, K. Ramachandran – 1 July 1992 – A prospective randomized study was conducted to compare the efficacy of long‐term endoscopic sclerotherapy vs. propranolol in Child class B and C patients with variceal bleeds within the 30 days before the study. Forty‐five and 46 patients were randomized to receive sclerotherapy and propranolol, respectively, after preentry stratification for Child scores. Sclerotherapy was administered with 1% polidocanol at 10‐day intervals until obliteration of varices was achieved.

Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis

Jean‐Michel Pawlotsky, Chantal Andre, Jean‐Michel Metreau, Michel Beaugrand, Elie‐Serge Zafrani, Daniel Dhumeaux – 1 July 1992 – Multiple nuclear dots antinuclear antibodies display a specific immunofluorescence pattern on HEp‐2 cells. They have been reported to be strongly associated with primary biliary cirrhosis, especially when sicca syndrome was present.

Neurological complications after liver retransplantation

Oscar L. Lopez, Conrado Estol, Immaculada Colina, Jorge Quiroga, Oscar C. Imvertarza, David H. Van Thiel – 1 July 1992 – Postoperative neurological complications in 185 patients who underwent two or more orthotopic liver transplantations were reviewed. The most common neurological complications were alteration of mental status (84%), seizures (33%) and focal motor deficits (15%). The frequency of neurological complications after a second orthotopic liver transplantation was significantly greater than that after a single orthotopic liver transplantation.

Uptake of a protein‐bound polar compound, acetaminophen sulfate, by perfused rat liver

Carl A. Goresky, K. Sandy Pang, Andreas J. Schwab, Ford Barker Iii, Wendy F. Cherry, Glen G. Bach – 1 July 1992 – The hepatocytic entry of acetaminophen sulfate conjugate was examined in the rat liver, perfused with red cells with and without albumin, by use of the multiple‐indicator dilution technique.

Subscribe to